Drugs / COVID-19 vaccine Pfizer
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05047718 | Oct 2021 → Aug 2022 | COVID-19 | University Hospital of Saint-Etienne | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COVID-19 vaccine Pfizer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05047718 ↗ |
| Modality | Vaccine | “COVID-19 vaccine Pfizer (3 doses)” NCT05047718 ↗ |